Shenzhen Kangtai Biological Products Co Ltd
Shenzhen Kangtai Biological Products Co., Ltd. researches and develops, produces, and sells various types of human vaccines in China. The company's marketed vaccines include 13-valent pneumococcal polysaccharide conjugate vaccine, varicella vaccine, freeze-dried, hepatitis B vaccine, inflammatory vaccine, 23-valent pneumococcal polysaccharide vaccine, DTAP/HIB combined vaccine, diphtheria, tetanu… Read more
Shenzhen Kangtai Biological Products Co Ltd (300601) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.042x
Based on the latest financial reports, Shenzhen Kangtai Biological Products Co Ltd (300601) has a cash flow conversion efficiency ratio of 0.042x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥405.44 Million) by net assets (CN¥9.61 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Shenzhen Kangtai Biological Products Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Shenzhen Kangtai Biological Products Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Shenzhen Kangtai Biological Products Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shenzhen Kangtai Biological Products Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
KLCC Property Holdings Bhd
KLSE:5235SS
|
0.021x |
|
Sezzle Inc.
NASDAQ:SEZL
|
0.213x |
|
Sanxiang Advanced Materials
SHG:603663
|
0.046x |
|
Bodycote plc
PINK:BYPLF
|
0.103x |
|
China Railway Hi-tech Industry Corp Ltd
SHG:600528
|
0.017x |
|
Sichuan Rongda Gold Co. Ltd. Cl A
SHE:001337
|
N/A |
|
Nuscale Power Corp
NYSE:SMR
|
-0.460x |
|
Port of Tauranga Limited
OTCGREY:PTAUF
|
0.016x |
Annual Cash Flow Conversion Efficiency for Shenzhen Kangtai Biological Products Co Ltd (2012–2024)
The table below shows the annual cash flow conversion efficiency of Shenzhen Kangtai Biological Products Co Ltd from 2012 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥9.66 Billion | CN¥603.25 Million | 0.062x | -42.33% |
| 2023-12-31 | CN¥9.54 Billion | CN¥1.03 Billion | 0.108x | +78.28% |
| 2022-12-31 | CN¥8.99 Billion | CN¥545.70 Million | 0.061x | -66.31% |
| 2021-12-31 | CN¥9.17 Billion | CN¥1.65 Billion | 0.180x | +205.85% |
| 2020-12-31 | CN¥7.46 Billion | CN¥439.85 Million | 0.059x | -67.90% |
| 2019-12-31 | CN¥2.75 Billion | CN¥505.70 Million | 0.184x | +0.01% |
| 2018-12-31 | CN¥1.83 Billion | CN¥336.48 Million | 0.184x | +27.69% |
| 2017-12-31 | CN¥1.07 Billion | CN¥153.98 Million | 0.144x | +34.92% |
| 2016-12-31 | CN¥735.00 Million | CN¥78.32 Million | 0.107x | -75.18% |
| 2015-12-31 | CN¥647.12 Million | CN¥277.85 Million | 0.429x | +123.70% |
| 2014-12-31 | CN¥583.81 Million | CN¥112.06 Million | 0.192x | +170.74% |
| 2013-12-31 | CN¥372.17 Million | CN¥26.38 Million | 0.071x | +482.01% |
| 2012-12-31 | CN¥431.21 Million | CN¥5.25 Million | 0.012x | -- |